Equillium, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| EQ | EDSA | ACTI.ST | EIKN | EVMN | MREO | |
|---|---|---|---|---|---|---|
| Market cap | 109.71M | 29.32M | 102.54M | 346.11M | 219.20M | 48.40M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -5.9 | — | — | -1.0 | -1.7 | -13.1 |
| Price/book | 1.6 | 52.9 | 2.8 | 0.7 | 0.8 | 1.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +11.90% | +27.65% | −34.67% | −63.00% | −70.64% | −82.78% |
| Today | −0.71% | −4.82% | +5.71% | +15.14% | +1.68% | +4.16% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All EQ news ›Equillium, Inc. (NASDAQ:EQ) Stock Has Average Target Price of $7.57 According to Brokerages
Posted by Defense World Staff on Oct 27th, 2026 Read Our Latest Research Report on EQ Equillium (NASDAQ:EQ – Get Free Report) last released its quarterly earnings results on Thursday, August 13th. The company reported ($0.04) earnings per…
Analysts Are Bullish on These Healthcare Stocks: PolyPid (PYPD), Equillium (EQ)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on PolyPid (PYPD) and Equillium (EQ) with bullish sentiments. In a report released yesterday, Boobalan Pachaiyappan from Roth MKM reiterated a Buy…
Calreticulin Is Not the MHC Class I Gatekeeper Immunology Textbooks Claimed
Bioengineer.org Subject of Research: The role of calreticulin and its oncogenic variants in MHC class I antigen presentation and T cell immune responses News Source: Kristina Jarvis. (October 17, 2026). Calreticulin Is Not t
Equillium clears Australian hurdle for first human trial of ulcerative colitis AhR modulator
La Jolla, California-based Equillium (Nasdaq: EQ) has received Australian clearance for a first-in-human trial of EQ504, an oral aryl hydrocarbon receptor (AhR) modulator being developed for ulcerative colitis. Dosing in healthy volunteers…
Shattuck Labs Announces Two Poster Presentations at UEG Week 2026
Presenter: Mahmud Hussain, Ph.D., Director, R&D of Shattuck Labs Date/Time: October 19, 2026; 1:00-2:00 p.m. CEST Title: Soluble TL1A/Anti-TL1A Immune Complexes Induce De Novo Production of TL1A and Induce Anti-Drug Antibodies That…
Review highlights EP4 receptor as target for inflammatory diseases
A review published in Genes & Diseases highlights the prostaglandin E2 receptor subtype 4 (EP4) as an important regulator of inflammation and a promising therapeutic target for a wide range of inflammatory and inflammation-related…
Eupraxia Pharmaceuticals Showcases EP-104GI EoE Data at Major Gastroenterology Meetings
Eupraxia Pharmaceuticals ( (TSE:EPRX) ) has shared an announcement. The most recent analyst rating on (TSE:EPRX) stock is a Buy with a C$19.00 price target. To see the full list of analyst forecasts on Eupraxia Pharmaceuticals stock, see…
Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504
On track to initiate dosing by early November 2026; topline Phase 1 proof-of-mechanism data anticipated approximately six months following study initiation As a potent and selective AhR modulator, EQ504 can affect both immune cell…
Equillium Announces Poster Presentations at the 7th International AHR Conference
LA JOLLA, Calif., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat... Equillium Announces Poster Presentations at the 7th International AHR Conference LA JOLLA,…
Eupraxia: 3 EP-104GI abstracts accepted for conferences
The Phase 2b RESOLVE study is recruiting at 120mg and 160mg, with interim data expected in December 2026. REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- markets.businessinsider.com7
- defenseworld.net1
- themarketsdaily.com1
- tipranks.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 10 articles, not a forecast.